Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NMT2 | O60551 | 1/20 | 0.44 |
| ▸ | NMT1 | P30419 | 1/20 | 0.44 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.41 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.41 |
| ▸ | FURIN | P09958 | 6/20 | 0.40 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.39 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.39 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.38 |
| ▸ | QRFPR | Q96P65 | 2/20 | 0.38 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29564895 | 0.90 | SLC15A2 (0.49) | NMT2NMT1SLC6A5SLC15A2FURIN | |
| SCHEMBL29380200 | 0.88 | SLC15A2 (0.49) | NMT2NMT1SLC6A5SLC15A2FURIN | |
| SCHEMBL29565229 | 0.87 | SLC15A2 (0.51) | NMT2NMT1SLC6A5SLC15A2FURIN | |
| SCHEMBL31232443 | 0.86 | NPY5R (0.42) | NMT2NMT1FURINQRFPR | |
| SCHEMBL30445587 | 0.85 | NMT1 (0.47) | NMT2NMT1SLC6A5FURINSIRT6 | |
| SCHEMBL5697801 | 0.84 | GNAI3 (0.42) | NMT2NMT1FURIN | |
| SCHEMBL3896673 | 0.84 | GNAI3 (0.42) | NMT2NMT1FURIN | |
| SCHEMBL15381920 | 0.84 | NMT1 (0.52) | NMT2NMT1FURINQRFPR | |
| SCHEMBL29420014 | 0.84 | MME (0.40) | SLC6A5 | |
| SCHEMBL11013340 | 0.84 | SIRT6 (0.48) | SLC15A2FURINSIRT6SIRT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110418837-B | Culture medium comprising oligopeptides | 赢创运营有限公司 | 2024-04-02 | — | — | CN | disclosed |